Cargando…

Transcriptomic signature of painful human neurofibromatosis type 2 schwannomas

Schwannomas are benign neoplasms that can cause gain‐ and loss‐of‐function neurological phenotypes, including severe, intractable pain. To investigate the molecular mechanisms underlying schwannoma‐associated pain we compared the RNA sequencing profile of painful and non‐painful schwannomas from NF2...

Descripción completa

Detalles Bibliográficos
Autores principales: Kukutla, Phanidhar, Ahmed, Sherif G., DuBreuil, Daniel M., Abdelnabi, Ahmed, Cetinbas, Murat, Fulci, Giulia, Aldikacti, Berent, Stemmer‐Rachamimov, Anat, Plotkin, Scott R., Wainger, Brian, Sadreyev, Ruslan I., Brenner, Gary J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8283170/
https://www.ncbi.nlm.nih.gov/pubmed/34053190
http://dx.doi.org/10.1002/acn3.51386
_version_ 1783723144863809536
author Kukutla, Phanidhar
Ahmed, Sherif G.
DuBreuil, Daniel M.
Abdelnabi, Ahmed
Cetinbas, Murat
Fulci, Giulia
Aldikacti, Berent
Stemmer‐Rachamimov, Anat
Plotkin, Scott R.
Wainger, Brian
Sadreyev, Ruslan I.
Brenner, Gary J.
author_facet Kukutla, Phanidhar
Ahmed, Sherif G.
DuBreuil, Daniel M.
Abdelnabi, Ahmed
Cetinbas, Murat
Fulci, Giulia
Aldikacti, Berent
Stemmer‐Rachamimov, Anat
Plotkin, Scott R.
Wainger, Brian
Sadreyev, Ruslan I.
Brenner, Gary J.
author_sort Kukutla, Phanidhar
collection PubMed
description Schwannomas are benign neoplasms that can cause gain‐ and loss‐of‐function neurological phenotypes, including severe, intractable pain. To investigate the molecular mechanisms underlying schwannoma‐associated pain we compared the RNA sequencing profile of painful and non‐painful schwannomas from NF2 patients. Distinct segregation of painful and non‐painful tumors by gene expression patterns was observed. Differential expression analysis showed the upregulation of fibroblast growth factor 7 (FGF7) in painful schwannomas. Behavioral support for this finding was observed using a xenograft human NF2‐schwannoma model in nude mice. In this model, over‐expression of FGF7 in intra‐sciatically implanted NF2 tumor cells generated pain behavior compared with controls.
format Online
Article
Text
id pubmed-8283170
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-82831702021-07-21 Transcriptomic signature of painful human neurofibromatosis type 2 schwannomas Kukutla, Phanidhar Ahmed, Sherif G. DuBreuil, Daniel M. Abdelnabi, Ahmed Cetinbas, Murat Fulci, Giulia Aldikacti, Berent Stemmer‐Rachamimov, Anat Plotkin, Scott R. Wainger, Brian Sadreyev, Ruslan I. Brenner, Gary J. Ann Clin Transl Neurol Brief Communications Schwannomas are benign neoplasms that can cause gain‐ and loss‐of‐function neurological phenotypes, including severe, intractable pain. To investigate the molecular mechanisms underlying schwannoma‐associated pain we compared the RNA sequencing profile of painful and non‐painful schwannomas from NF2 patients. Distinct segregation of painful and non‐painful tumors by gene expression patterns was observed. Differential expression analysis showed the upregulation of fibroblast growth factor 7 (FGF7) in painful schwannomas. Behavioral support for this finding was observed using a xenograft human NF2‐schwannoma model in nude mice. In this model, over‐expression of FGF7 in intra‐sciatically implanted NF2 tumor cells generated pain behavior compared with controls. John Wiley and Sons Inc. 2021-05-30 /pmc/articles/PMC8283170/ /pubmed/34053190 http://dx.doi.org/10.1002/acn3.51386 Text en © 2021 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Brief Communications
Kukutla, Phanidhar
Ahmed, Sherif G.
DuBreuil, Daniel M.
Abdelnabi, Ahmed
Cetinbas, Murat
Fulci, Giulia
Aldikacti, Berent
Stemmer‐Rachamimov, Anat
Plotkin, Scott R.
Wainger, Brian
Sadreyev, Ruslan I.
Brenner, Gary J.
Transcriptomic signature of painful human neurofibromatosis type 2 schwannomas
title Transcriptomic signature of painful human neurofibromatosis type 2 schwannomas
title_full Transcriptomic signature of painful human neurofibromatosis type 2 schwannomas
title_fullStr Transcriptomic signature of painful human neurofibromatosis type 2 schwannomas
title_full_unstemmed Transcriptomic signature of painful human neurofibromatosis type 2 schwannomas
title_short Transcriptomic signature of painful human neurofibromatosis type 2 schwannomas
title_sort transcriptomic signature of painful human neurofibromatosis type 2 schwannomas
topic Brief Communications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8283170/
https://www.ncbi.nlm.nih.gov/pubmed/34053190
http://dx.doi.org/10.1002/acn3.51386
work_keys_str_mv AT kukutlaphanidhar transcriptomicsignatureofpainfulhumanneurofibromatosistype2schwannomas
AT ahmedsherifg transcriptomicsignatureofpainfulhumanneurofibromatosistype2schwannomas
AT dubreuildanielm transcriptomicsignatureofpainfulhumanneurofibromatosistype2schwannomas
AT abdelnabiahmed transcriptomicsignatureofpainfulhumanneurofibromatosistype2schwannomas
AT cetinbasmurat transcriptomicsignatureofpainfulhumanneurofibromatosistype2schwannomas
AT fulcigiulia transcriptomicsignatureofpainfulhumanneurofibromatosistype2schwannomas
AT aldikactiberent transcriptomicsignatureofpainfulhumanneurofibromatosistype2schwannomas
AT stemmerrachamimovanat transcriptomicsignatureofpainfulhumanneurofibromatosistype2schwannomas
AT plotkinscottr transcriptomicsignatureofpainfulhumanneurofibromatosistype2schwannomas
AT waingerbrian transcriptomicsignatureofpainfulhumanneurofibromatosistype2schwannomas
AT sadreyevruslani transcriptomicsignatureofpainfulhumanneurofibromatosistype2schwannomas
AT brennergaryj transcriptomicsignatureofpainfulhumanneurofibromatosistype2schwannomas